Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
150 USD | -0.28% | -0.22% | -21.78% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.78% | 19.03B | |
+45.05% | 56.65B | |
-6.85% | 39.44B | |
+39.04% | 39.03B | |
-11.17% | 26.86B | |
+12.62% | 26.75B | |
+1.43% | 12.28B | |
+24.62% | 12.26B | |
+27.15% | 12.04B | |
-12.09% | 10.71B |
- Stock Market
- Equities
- ALNY Stock
- News Alnylam Pharmaceuticals, Inc.
- Alnylam Pharmaceuticals Halts Late-Stage Trial on Eye Disorder Treatment